Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2016 01:18 ET | Source: SymBio Pharmaceuticals Ltd

Initiation of Phase 3 Clinical Trial on the Patient-controlled Pain Management Drug "SyB P-1501"

TOKYO, June 13, 2016 (GLOBE NEWSWIRE) -- SymBio Pharmaceuticals Limited (Headquarters: Tokyo, “SymBio”) announced today that the Phase 3 clinical trial on “SyB P-1501” – a drug for...